Emerging therapies: ESPRIT

Stroke

Volumn 38, Issue 4, 2007, Pages 1142-

  Moussouttas, Michael ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

CEREBROVASCULAR ACCIDENT; DATA ANALYSIS; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THERAPY EFFECT; THROMBOSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG COMBINATION; NOTE; PATHOPHYSIOLOGY; REPRODUCIBILITY; STANDARD; STATISTICS;

ASPIRIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS;

EID: 34247887671     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000259782.17562.fc     Document Type: Letter

References (10)

1. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-1673.
2. Diener H. How much esprit is in ESPRIT? Stroke. 2006;37:2856-2857.
3. Leon M, Baim D, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. N Engl J Med. 1998;339:1665-1671.
4. Yusuf S, Zhao F, Mehta S, Chrolavicius S, Tognoni G, Fox K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
5. COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction. Lancet. 2005;366:1607-1621.
6. Diener H, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
7. Diener H, Bogousslavsky J, Brass L, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
8. Bhatt D, Fox K, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006; 354:1706-1717.
9. Albers G, Amarenco P, Easton J, Sacco R, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483S-512S.
10. Sacco R, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; AHA; ASA Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for Prevention of Stroke in Patients with Isolated Stroke or Transient Ischemic Attack. Stroke. 2006;37:577-617.